Cargando…
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches
Despite extensive research efforts, advanced gastric cancer still has a dismal prognosis with conventional treatment options. Immune checkpoint inhibitors have revolutionized the treatment landscape for many solid tumors. Amongst gastric cancer subtypes, tumors with microsatellite instability and Ep...
Autores principales: | Ghidini, Michele, Petrillo, Angelica, Botticelli, Andrea, Trapani, Dario, Parisi, Alessandro, La Salvia, Anna, Sajjadi, Elham, Piciotti, Roberto, Fusco, Nicola, Khakoo, Shelize |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037391/ https://www.ncbi.nlm.nih.gov/pubmed/33915839 http://dx.doi.org/10.3390/jcm10071412 |
Ejemplares similares
-
Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer
por: Indini, Alice, et al.
Publicado: (2021) -
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
por: Ghidini, Michele, et al.
Publicado: (2019) -
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
por: Khakoo, Shelize, et al.
Publicado: (2021) -
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2023) -
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
por: Venetis, Konstantinos, et al.
Publicado: (2021)